New Polaris® IVD Reagents: Essential for Accurate Molecular Diagnostics_NZYTech - 코아사이언스

New Polaris® IVD Reagents: Essential for Accurate Molecular Diagnostics

 

The Polaris® suite of in vitro diagnostic (IVD) reagents is designed to excel under the rigorous demands of diagnostic testing, ensuring high performance across a broad spectrum of applications. NZYTech has just launched a new addition of IVD reagents to its Polaris® product suite. These new IVD products are robust Class A diagnostic reagents  engineered to deliver consistent and reliable results, accommodating varied diagnostic demands and performing seamlessly across different biological matrices and testing conditions.

Diagnostic laboratories require reagents that not only deliver high sensitivity and specificity but also ensure stability and reproducibility. The Polaris® product line addresses these needs with an array of highly optimized IVD reagents, each validated through extensive testing to guarantee their reliability in detecting a wide spectrum of viral and bacterial pathogens.

Polaris® IVD reagents are designed to enhance the capabilities of molecular diagnostic labs. The range includes:

Polaris® Taq Polymerase 50 U/µL, IVD: A highly concentrated enzyme ideal for bulk PCR master mix production, offering rapid amplification without compromising specificity or sensitivity, even in challenging and multiplex PCR applications.

Polaris® HS Taq Polymerase 20 U/µL, IVD: Featuring an anti-Taq antibody for hot-start PCR, this enzyme minimizes non-specific amplification, ensuring high yield and specificity in singleplex, duplex, and multiplex PCR.

Polaris® Glycerol-free Taq Antibody 10 mg/mL, IVD: Optimized for hot-start PCR, this glycerol-free formulation ensures compatibility with lyophilization processes, enhancing PCR assay performance.

Polaris® Reverse Transcriptase 285 U/µL, IVD: This enzyme ensures efficient and accurate cDNA synthesis from RNA templates, crucial for reliable RT-qPCR diagnostics.

Polaris® dNTP mix 25 mM, IVD: A balanced nucleotide mix that enhances PCR accuracy and reliability, suitable for various PCR applications, including diagnostic RT-PCR and qPCR.

Polaris® RNase Inhibitor 80 U/µL, IVD: Protects RNA from degradation, ensuring the integrity of samples during critical diagnostic processes.

Polaris® qPCR Buffer 2.5x, IVD: Optimized for sensitive and specific molecular diagnostics, ensuring reliable PCR performance.

Polaris® RT-qPCR Buffer 2.5x, IVD: A comprehensive buffer solution that stabilizes and enhances enzyme activity for superior RT-qPCR performance.

Each reagent in the Polaris® suite has been validated under rigorous quality management systems, adhering to global standards for medical devices and IVD manufacturing. This extensive validation includes detecting a range of pathogens such as SARS-CoV-2, RSV, Influenza, MRSA, and high-risk HPV types, ensuring reliability across diverse clinical matrices.

Polaris® IVD reagents stand out for their high sensitivity, specificity, stability, and reproducibility. These features make them indispensable for molecular diagnostics laboratories aiming to achieve precise and reliable results. The Polaris® suite's comprehensive validation and high-performance standards underscore its capability to meet varied diagnostic needs, making it the preferred choice for molecular testing facilities.

By integrating Polaris® IVD reagents into your diagnostic workflows, you ensure that your laboratory can deliver accurate and dependable diagnostic results, supporting better patient outcomes and advancing the field of molecular diagnostics.

 

* 본 상품은 오직 연구용으로만 사용 가능합니다. 인체 및 제품화에 사용하실 수 없습니다.

 

코아사이언스 coresciences NZYTech, Lda. genes & enzymes korea 한국 molecular biology 분자생물학 enzymes & proteins 효소 단백질 assay kits 분석 측정 테스트 키트